For instance, TGF-β can inhibit the expression of NK cell receptors including NKp30 and NKG2D, which is essential for tumor recognition and elimination by NK cells and for their productive interaction with DCs (Castriconi et al., 2003). Here, NCR3 is linked to neoplasm.